The rising prevalence in GLP-1 agonists for diabetes has generated a debate about delivery methods : skin-applied devices versus pills . Usually , GLP-1 therapies were only available in oral form, but the https://jeanlxll242717.activablog.com/39979534/glp-1-skin-applications-vs-pills-is-right-for-you